Learn how a new genetic therapy could transform treatment for rare ALS—keep reading for remarkable patient outcomes.

EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6.

Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt ...

Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

By Kamal Choudhury (Reuters) -ITeos Therapeutics plans to wind down its operations and sell its assets, including experimental cancer treatments and an obesity drug, the company said on Wednesday, two ...

Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

Teos Therapeutics (ITOS) stock surges 25% as the company announces plans to wind down operations, focusing on shareholder ...

Scientists at Duke University have developed a new experimental drug that may offer strong pain relief without the risks ...

Doechii has grown up with an alligator named Coconut, or Coco to friends. The two have been through a lot together: music videos, mixtape covers, and now, a new campaign with Samsung for their Galaxy ...

The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the foundations of health care, for global and US citizens alike. What started ...